VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
50 hedge funds and large institutions have $33.6M invested in Viracta Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 7 closing their positions.
Holders
50
Holders Change
–
Holders Change %
0%
% of All Funds
1.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
8
Reduced
12
Closed
7
Calls
$816K
Puts
$258K
Net Calls
+$558K
Net Calls Change
+$24K